Human IgG Quick test strip |
|
E411A02-10 |
EnoGene |
10 tests |
EUR 150 |
|
|
Human IgG antibody Laboratories manufactures the sars bio hit test reagents distributed by Genprice. The Sars Bio Hit Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars products are available in stock. Specificity: Sars Category: Bio Group: Hit Test
Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit |
|
Abbexa |
100 µl |
EUR 225 |
Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit |
|
Abbexa |
1 ml |
Ask for price |
Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit |
|
Abbexa |
200 µl |
EUR 350 |
Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit |
|
Abbexa |
100 µl |
EUR 225 |
Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit |
|
Abbexa |
1 ml |
Ask for price |
Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit |
|
Abbexa |
200 µl |
EUR 350 |
Hit Test information
Antibody Bio-Stabilizer 10X |
|
22050005-2 |
Bio-WORLD |
50 mL |
EUR 105.44 |
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
|
GEN-402-25tests |
All test |
25 tests |
EUR 292.8 |
|
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
SARS-CoV-2 Antigen Rapid Test Kit |
|
abx294181-100g |
Abbexa |
100 µg |
EUR 850 |
SARS-CoV-2 Antigen Rapid Test Kit |
|
abx294181-20g |
Abbexa |
20 µg |
EUR 100 |
SARS-CoV-2 Antigen Rapid Test Kit |
|
abx294181-50g |
Abbexa |
50 µg |
EUR 450 |
SARS-CoV-2 Antigen Rapid Test Kit |
|
CoV2Ag-1 |
UnScience |
1T |
EUR 9.6 |
|
|
|
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again. |
SARS-CoV-2 Antigen Rapid Test Kit |
|
CoV2Ag-25 |
UnScience |
25T/kit |
EUR 42 |
|
|
|
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection. |
SARS Associated Coronavirus Nucleocaspid (340-390) (Recombinant) |
|
22060693-1 |
Bio-WORLD |
100 µg |
EUR 344.89 |
SARS AssociatedCoronavirus Nucleocaspid (1-49,192-220) (Recombinant) |
|
22060687-1 |
Bio-WORLD |
100 µg |
EUR 344.89 |
SARS-CoV-2 Rapid Antigen Test Nasal |
|
9901-NCOV-03G |
Roche Diagnostics |
25 Tests/Kit |
EUR 112.8 |
|
|
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
SARS-CoV-2/COVID-19 RT-qPCR Detection Kit (RUO) |
|
QP019-0100 |
Bio-Helix |
100 rxns |
Ask for price |
SARS-CoV-2 IgG/IgM Rapid Test Kit |
|
abx294171-100g |
Abbexa |
100 µg |
EUR 1525 |
SARS-CoV-2 IgG/IgM Rapid Test Kit |
|
abx294171-20g |
Abbexa |
20 µg |
EUR 187.5 |
SARS-CoV-2 IgG/IgM Rapid Test Kit |
|
abx294171-50g |
Abbexa |
50 µg |
EUR 337.5 |
Test Tube, 12x75mm, 5mL, PP, rimless, no cap, non-sterile, 8 bags of 500 tubes, 4000/cs |
|
T1221 |
MTC Bio |
4000 |
EUR 375 |
DMSO Bio-Max, Cell Culture Grade |
|
40470005-1 |
Bio-WORLD |
50 mL |
EUR 107.8 |
|
|